Dealkylation and N-Oxidation in the Metabolism of I-Diethylcarbamyl-4-Methylpiperazine in the Rat
- 1 January 1972
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 2 (1), 59-68
- https://doi.org/10.3109/00498257209036234
Abstract
1. When [14C]1-diethylcarbamyl-4-methylpiperazine was orally administered to rats, 97% of the radioactivity was excreted in the 24 h urine. Unchanged drug excreted in the urine accounted for about 15% of the dose. 2. Two major metabolites present in the urine have been identified as 1-ethylcarbamyl-4-methylpiperazine (about 23% dose) and as 1-diethylcarbamyl-4-methylpiperazine-4-oxide (about 50% dose).Keywords
This publication has 6 references indexed in Scilit:
- Controlled anthelmintic trials in experimentally-infected calves with a combination of morantel and diethylcarbamazinePublished by Wiley ,1972
- Controlled anthelmintic trials in sheep with a combination of morantel and diethylcarbamazinePublished by Wiley ,1971
- Amine Oxides. VII. The Thermal Decomposition of the N-Oxides of N-Methylazacycloalkanes1,2Journal of the American Chemical Society, 1960
- 791. The synthesis of14C-labelled diethylcarbamazine, 1-diethylcarbamyl-4-methylpiperazine (“Hetrazan”)Journal of the Chemical Society, 1953
- Some recent work on filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1950
- EXPERIMENTAL CHEMOTHERAPY OF FILARIASIS. V. THE PREPARATION OF DERIVATIVES OF PIPERAZINEThe Journal of Organic Chemistry, 1948